Form D · Biotechnology

GENVAULT Corp

Carlsbad, CA · CIK 0001226221

Offering snapshot reported Nov 24, 2010 · SEC filing

Reported sold
$6.8M
Offering amount: $6.84M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 13, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$3.4M$6.8MNov 25, 2009: $2,002,000.00Nov 25, 2009Jun 15, 2010: $5,300,295.00Jun 15, 2010Sep 30, 2010: $6,301,295.00Nov 24, 2010: $6,801,794.00Nov 24, 2010

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$6,301,295 → $6,801,794

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 24, 2010Amendment$6,801,794$500,499vs Sep 30, 201010SEC filing
Sep 30, 2010Amendment$6,301,295$1,001,000vs Jun 15, 201010SEC filing
Jun 15, 2010Amendment$5,300,295$3,298,295vs Nov 25, 200910SEC filing
Nov 25, 2009Initial$2,002,000No comparison10SEC filing
Jun 17, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired, Other
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-54107
Includes approximately $35,223.19 receivable by the Company upon the exercise of Warrants to purchase shares of the Company's Common Stock, assuming no cashless exercise. Such Warrants have not yet been exercised.
Warrants to Purchase Common Stock and Common Stock issuable upon exercise of the Warrants.

Source: Form D, filed Nov 24, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James C. Blair, Ph.D. Director
William R. Brody, M.D., Ph.D. Director
Jay Flatley Director
Erik Holmlin Executive
Paul J. Mirabella Director
Benjamin S. Schapiro Director
John Spilman Director
David Wellis, Ph.D. Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
6190 Corte Del Cedro
Carlsbad, CA, 92011